Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25535
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWilliams, Michael-
dc.contributor.authorPerera, Marlon-
dc.contributor.authorNouhaud, François Xavier-
dc.contributor.authorCoughlin, Geoffrey-
dc.date.accessioned2021-01-04T23:56:32Z-
dc.date.available2021-01-04T23:56:32Z-
dc.date.issued2021-01-
dc.identifier.citationInvestigative and Clinical Urology 2021-01; 62(1): 111-120en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25535-
dc.description.abstractTo describe the surgical technique and examine the feasibility and outcomes following robotic pelvic exenteration and extended pelvic resection for rectal and/or urological malignancy. We present a case series of seven patients with locally advanced or synchronous urological and/or rectal malignancy who underwent robotic total or posterior pelvic exenteration between 2012-2016. In total, we included seven patients undergoing pelvic exenteration or extended pelvic resection. The mean operative time was 485±157 minutes and median length of stay was 9 days (6-34 days). There was only one Clavien-Dindo complication grade 3 which was a vesicourethral anastomotic leak requiring rigid cystoscopy and bilateral ureteric catheter insertion. Eighty-five percent of patients had clear colorectal margins with a median margin of 3.5 mm (0.7-8.0 mm) while all urological margins were clear. Six out of seven patients had complete (grade 3) total mesorectal excision. Three patients experienced recurrence at a median of 22 months (21-24 months) post-operatively. Of the three recurrences, one was systemic only whilst two were both local and systemic. One patient died from complications of dual rectal and prostate cancer 31 months after the surgery. We report a large series examining robotic pelvic exenteration or extended pelvic resection and describe the surgical technique involved. The robotic approach to pelvic exenteration is highly feasible and demonstrates acceptable peri-operative and oncological outcomes. It has the potential to benefit patients undergoing this highly complex and morbid procedure.en
dc.language.isoeng
dc.subjectColorectal canceren
dc.subjectMinimally invasive surgical proceduresen
dc.subjectPelvic exenterationen
dc.subjectProstate canceren
dc.subjectSurgeryen
dc.titleRobotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.en
dc.typeJournal Articleen
dc.identifier.journaltitleInvestigative and Clinical Urologyen
dc.identifier.affiliationSurgery (University of Melbourne)en
dc.identifier.affiliationDepartment of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australiaen
dc.identifier.affiliationDepartment of Surgery, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australiaen
dc.identifier.doi10.4111/icu.20200176en
dc.type.contentTexten
dc.identifier.orcid0000-0002-3389-3875en
dc.identifier.orcid0000-0002-1138-6389en
dc.identifier.orcid0000-0003-3764-9949en
dc.identifier.orcid0000-0003-0443-7966en
dc.identifier.pubmedid33381928
Appears in Collections:Journal articles
Files in This Item:
3 files
File Description SizeFormat 
25535.pdf4.39 MBAdobe PDF
Download Adobe
Thumbnail
View/Open
Show simple item record

Page view(s)

18
checked on Jun 22, 2021

Download(s)

34
checked on Jun 22, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.